Metastasectomy for rectal wall seeding of prostate adenocarcinoma after transrectal prostate biopsy.

Needle track Prostate biopsy Seeding Transrectal prostate biopsy

Journal

Urology case reports
ISSN: 2214-4420
Titre abrégé: Urol Case Rep
Pays: United States
ID NLM: 101626357

Informations de publication

Date de publication:
Jan 2021
Historique:
received: 25 09 2020
accepted: 08 10 2020
entrez: 26 10 2020
pubmed: 27 10 2020
medline: 27 10 2020
Statut: epublish

Résumé

Definitive treatment for local prostate cancer recurrence remains controversial. Early recurrences are often from positive surgical margins or nodal metastases, however other explanations should be considered. We present a case of a 79 year-old male with localized prostate cancer and early biochemical persistence after margin-negative robotic-assisted radical prostatectomy. Workup demonstrated a 0.9 cm rectal mass without nodal or distant metastasis, and biopsy revealed prostate adenocarcinoma. A subsequent transanal excision was performed. Post-operatively, his PSA dropped to 0.02 ng/mL. We present a rare case of prostate adenocarcinoma seeding after transrectal prostate biopsy and a review of the literature.

Identifiants

pubmed: 33102128
doi: 10.1016/j.eucr.2020.101445
pii: S2214-4420(20)30334-X
pmc: PMC7569293
doi:

Types de publication

Case Reports

Langues

eng

Pagination

101445

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Urol. 1989 Jul;142(1):86-8
pubmed: 2733112
J Urol. 1966 Jun;95(6):801-4
pubmed: 5937648
BJU Int. 2015 May;115(5):698-704
pubmed: 24958224
Eur Urol. 2013 Dec;64(6):876-92
pubmed: 23787356
Eur J Nucl Med Mol Imaging. 2018 Feb;45(2):235-242
pubmed: 29075832

Auteurs

E Matthew DiLizia (EM)

Department of Urology, MedStar Georgetown University Hospital, Washington, DC, USA.

Michael Ahdoot (M)

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Michael Daneshvar (M)

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Patrick T Gomella (PT)

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Nitin K Yerram (NK)

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Peter A Pinto (PA)

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

Classifications MeSH